Literature DB >> 2722239

Retention of bacterial lipopolysaccharide at the site of subcutaneous injection.

T Yokochi1, Y Inoue, J Yokoo, Y Kimura, N Kato.   

Abstract

The tissue distribution of Klebsiella pneumoniae O3 lipopolysaccharide (KO3 LPS) was studied in mice injected subcutaneously (s.c.) or intraperitoneally (i.p.) with 125I-labeled KO3 LPS. Marked retention of KO3 LPS radioactivity could be found at the site of s.c. injection for several weeks. On the other hand, about 85% of the radioactivity rapidly disappeared from the peritoneal cavity within 6 h after i.p. injection. The long-term presence of KO3 LPS at the injection site was also supported by experiments with 51Cr-labeled KO3 LPS and immunoblotting and immunofluorescence staining methods. The R-form LPS lacking the O-specific polysaccharide chain of KO3 LPS and the lipid A fraction of KO3 LPS seemed to remain at the site in larger amounts and for longer times than KO3 LPS. There were no marked differences in the retention pattern at the injection site among KO3 LPS, Escherichia coli LPS, Salmonella typhosa LPS, and Salmonella enteritidis LPS. However, much less radioactivity accumulated in the livers and spleens of mice injected with either KO3 LPS or S. typhosa LPS compared with the other LPS preparations. It was suggested that retention of LPS at the site of s.c. injection may play an important role in the development of various biological actions of s.c. injected LPS.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2722239      PMCID: PMC313357          DOI: 10.1128/iai.57.6.1786-1791.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

2.  Effect of capsular polysaccharide of Klebsiella pneumoniae on the differentiation and functional capacity of macrophages cultured in vitro.

Authors:  T Yokochi; I Nakashima; N Kato
Journal:  Microbiol Immunol       Date:  1977-10-20       Impact factor: 1.955

3.  Microbial adjuvant and autoimmunity. II. Production of lesions in mice immunized with syngeneic tissue extracts together with the capsular polysaccharide of Klebsiella pneumoniae.

Authors:  I Nakashima; T Yokochi; N Kato; J Asai
Journal:  Microbiol Immunol       Date:  1977       Impact factor: 1.955

4.  The identification of actin as a major lymphocyte component.

Authors:  B H Barber; T L Delovitch
Journal:  J Immunol       Date:  1979-01       Impact factor: 5.422

5.  Adjuvant actions of polyclonal lymphocyte activators. III. Two distinct types of T-initiating adjuvant action demonstrated under different experimental conditions.

Authors:  I Nakashima; F Nagase; A Matsuura; T Yokochi; N Kato
Journal:  Cell Immunol       Date:  1980-07-01       Impact factor: 4.868

6.  Cellular aspects of non-specific stimulation of antibody production by capsular polysaccharide of Klebsiella pneumoniae.

Authors:  I Nakashima; T Kojima; N Kato
Journal:  Immunology       Date:  1976-02       Impact factor: 7.397

7.  Adjuvant action of capsular polysaccharide of Klebsiella pneumoniae on antibody response. IX. Its effect on the histology of the regional lymph node and other lymphoid organs.

Authors:  T Yokochi; I Nakashima; N Kato; J Asai; S Iijima
Journal:  Microbiol Immunol       Date:  1980       Impact factor: 1.955

8.  Further studies of the polysaccharide of Klebsiella pneumoniae possessing strong adjuvanticity. II. Serological relationship between the adjuvant polysaccharide and O3 antigen of Klebsiella.

Authors:  N Kato; M Ohta; T Hasegawa; M Mori; K Yamaki; K Mizuta; I Nakashima; S Naito
Journal:  Microbiol Immunol       Date:  1981       Impact factor: 1.955

9.  Further Studies of the polysaccharide of Klebsiella pneumoniae possessing strong adjuvanticity. I. Production of the adjuvant polysaccharide by noncapsulated mutant.

Authors:  M Ohta; M Mori; T Hasegawa; F Nagase; I Nakashima; S Naito; N Kato
Journal:  Microbiol Immunol       Date:  1981       Impact factor: 1.955

10.  Further studies of the polysaccharide of Klebsiella pneumoniae possessing strong adjuvanticity. III. Augmentation of the antibody response to subcutaneously injected sheep red blood cells by the adjuvant polysaccharide.

Authors:  T Yokochi; I Nakashima; F Nagase; N Kato; M Ohta; Y Fujii; K Mizoguchi; K Isobe; M Saito
Journal:  Microbiol Immunol       Date:  1982       Impact factor: 1.955

View more
  17 in total

Review 1.  Adjuvants for vaccines to drugs of abuse and addiction.

Authors:  Carl R Alving; Gary R Matyas; Oscar Torres; Rashmi Jalah; Zoltan Beck
Journal:  Vaccine       Date:  2014-08-08       Impact factor: 3.641

Review 2.  Endotoxemia-menace, marker, or mistake?

Authors:  Robert S Munford
Journal:  J Leukoc Biol       Date:  2016-07-14       Impact factor: 4.962

3.  Differential release of smooth-type lipopolysaccharide from Pseudomonas aeruginosa treated with carbapenem antibiotics and its relation to production of tumor necrosis factor alpha and nitric oxide.

Authors:  T Yokochi; A Kusumi; N Kido; Y Kato; T Sugiyama; N Koide; G Z Jiang; K Narita; K Takahashi
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

4.  Complement-dependent accumulation and degradation of platelets in the lung and liver induced by injection of lipopolysaccharides.

Authors:  M Shibazaki; Y Kawabata; T Yokochi; A Nishida; H Takada; Y Endo
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

5.  A murine model of experimental autoimmune lens-induced uveitis using Klebsiella O3 lipopolysaccharide as a potent immunological adjuvant.

Authors:  T Yokochi; Y Fujii; I Nakashima; J Asai; M Kiuchi; K Kojima; N Kato
Journal:  Int J Exp Pathol       Date:  1993-12       Impact factor: 1.925

6.  Binding of mannose-binding protein to Klebsiella O3 lipopolysaccharide possessing the mannose homopolysaccharide as the O-specific polysaccharide and its relation to complement activation.

Authors:  G Z Jiang; T Sugiyama; Y Kato; N Koide; T Yokochi
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

7.  Novel adjuvant action of lipopolysaccharides that possess mannose homopolysaccharides as O-specific polysaccharides on immune responses to nonimmunogenic autoantigens in mice.

Authors:  T Yokochi; M Fukada; M Kawai; Y H Zhang; G Z Jiang; K Takahashi
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

8.  In vivo induction of apoptosis (programmed cell death) in mouse thymus by administration of lipopolysaccharide.

Authors:  Y H Zhang; K Takahashi; G Z Jiang; M Kawai; M Fukada; T Yokochi
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

9.  In vivo production of heat shock protein in mouse peritoneal macrophages by administration of lipopolysaccharide.

Authors:  Y H Zhang; K Takahashi; G Z Jiang; X M Zhang; M Kawai; M Fukada; T Yokochi
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

10.  Augmented immunological activities of recombinant lipopolysaccharide possessing the mannose homopolymer as the O-specific polysaccharide.

Authors:  N Paeng; N Kido; G Schmidt; T Sugiyama; Y Kato; N Koide; T Yokochi
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.